#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Characteristics of sarcopenia after distal gastrectomy in elderly patients


Autoři: Sadamu Takahashi aff001;  Shota Shimizu aff001;  Satoshi Nagai aff001;  Hiroshi Watanabe aff001;  Yuuko Nishitani aff001;  Yasuro Kurisu aff001
Působiště autorů: Department of Surgery, National Hospital Organization Hamada Medical Center, Asai-tyou, Hamada, Japan aff001
Vyšlo v časopise: PLoS ONE 14(9)
Kategorie: Research Article
doi: https://doi.org/10.1371/journal.pone.0222412

Souhrn

Presence of preoperative sarcopenia is a risk factor for postoperative complications. However, there are few reports on the presence of sarcopenia and its characteristics following gastrectomy. Sarcopenia is closely related to quality of life in elderly people. To date, the main purpose of follow-up after gastrectomy is surveillance for early detection of recurrence and secondary cancer. However, henceforth, quality of life in elderly gastric cancer patients after gastrectomy must also be evaluated. The present study aimed to investigate sarcopenia during a 1-year postoperative course in elderly gastric cancer patients and examine their characteristics. The subjects were 50 patients aged ≥70 years who underwent laparoscopy-assisted distal gastrectomy for gastric cancer and who experienced no recurrence 1 year postoperatively. Height, weight, serum albumin levels, food intake amount, grip strength, gait speed, visceral fat area, and appendicular skeletal muscle mass index were measured preoperatively and 6 months and 1 year postoperatively. Sarcopenia, obesity, and visceral obesity were diagnosed. Compared with preoperatively, indicators other than height decreased 6 months postoperatively. Compared with 6 months postoperatively, body weight, amount of food intake, and visceral fat area increased by 1 year postoperatively, unlike appendicular skeletal muscle mass index. The frequency of sarcopenia increased 6 months postoperatively compared with preoperatively; this frequency remained almost unchanged 1 year postoperatively compared with 6 months postoperatively. Further, the frequency of visceral obesity increased 1 year postoperatively compared with 6 months postoperatively. Weight increased after > 6 months postoperatively; however, most of the weight increase was in terms of fat and not muscle. We emphasize the importance of considering postoperative sarcopenia and visceral obesity. In particular, sarcopenia and visceral obesity should be carefully monitored after increases in body mass index and food consumption.

Klíčová slova:

Medicine and health sciences – Diagnostic medicine – Signs and symptoms – Sarcopenia – Pathology and laboratory medicine – Surgical and invasive medical procedures – Digestive system procedures – Gastrectomy – Body weight – Muscles – Skeletal muscles – Oncology – Cancers and neoplasms – Gastrointestinal tumors – Gastric cancer – Geriatrics – Biology and life sciences – Physiology – Physiological parameters – Obesity – Biochemistry – Lipids – Fats – Anatomy – Musculoskeletal system – People and places – Population groupings – Age groups – Elderly


Zdroje

1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39: 412–423. doi: 10.1093/ageing/afq034 20392703

2. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia; Consensus Report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15: 95–101. doi: 10.1016/j.jamda.2013.11.025 24461239

3. Gariballa S, Alessa A. Sarcopenia: prevalence and prognostic significance in hospitalized patients. Clin Nutr. 2013;32:772–6. doi: 10.1016/j.clnu.2013.01.010 23395102

4. Oliveira A, Vaz C. The role of sarcopenia in the risk of osteoporotic hip fracture. Clin Rheumatol. 2015;34: 1673–1680. doi: 10.1007/s10067-015-2943-9 25912213

5. Chin SO, Rhee SY, Chon S, Hwang YC, Jeong IK, Oh S, et al. Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2009. PLoS One. 2013;8: e60119. doi: 10.1371/journal.pone.0060119 23533671

6. Harimoto N, Shirabe K, Yamashita YI, Ikegami T, Yoshizumi T, Soejima Y, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg. 2013;100: 1523–1530. doi: 10.1002/bjs.9258 24037576

7. Kaido T, Ogawa K, Fujimoto Y, Ogura Y, Hata K, Ito T, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant. 2013;13: 1549–1556. doi: 10.1111/ajt.12221 23601159

8. Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107: 931–936. doi: 10.1038/bjc.2012.350 22871883

9. Dong-Dong H, Chong-Jun Z, Su-Lin W, Shu-Ting M, Xuan-You Z, Neng L, et al. Impact of different sarcopenia stages on the postoperative outcomes after radical gastrectomy for gastric cancer. Surgery. 2017;161: 680–693. doi: 10.1016/j.surg.2016.08.030 27712873

10. Fukuda Y, Yamamoto K, Hirao M, Nishikawa K, Nagatsuma Y, Nakayama T, et al. Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy. Gastric Cancer. 2016;19: 986–993. doi: 10.1007/s10120-015-0546-4 26407875

11. Takahashi S, Maeta M, Mizusawa K, Kaneko T, Naka T, Ashida K, et al. Long-term postoperative analysis of nutritional status after limited gastrectomy for early gastric cancer. Hepatogastroenterology. 1998;45: 889–894. 9684153

12. Katai H, Ishikawa T, Akazawa K, Isobe Y, Miyashiro I, Oda I, et al. Five-year survival analysis of surgically resected gastric cancer cases in japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007). Gastric Cancer. 2018;21: 144–154. doi: 10.1007/s10120-017-0716-7 28417260

13. Japanese gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014(ver. 4). Gastric Cancer. 2017;20: 1–19.

14. Kyle UG, Genton L, Hans D, Pichard C. Validation of a bioelectrical impedance analysis equation to predict appendicular skeletal muscle mass(ASMM). Clin Nutr. 2003;22: 537–543. 14613755

15. Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol. 2000;89: 465–471. 10926627

16. Takahashi S, Kurisu Y, Nagai S, Watanabe H, Nishitani Y, Ishiguro S. The cutoff value of Japanese appendicular skeletal muscle mass-measurements using bioelectrical impedance analyzer (in Japanese). J Shimane M A. 2016;36: 46–51.

17. Japan Society for the Study of Obesity. Guidelines for the management of obesity disease 2016. 1st ed. Tokyo: Lifescience Press; 2016.

18. Office for Resources Policy Division, Science and technology Policy Bureau Ministry of Education, Culture, Sports, Science and Technology, Japan. Standard Tables of Food Composition in Japan-2015-(Seventh Revised Version). 2015. Available from: http://www.mext.go.jp/amenu/syokuhinseibun/1365295.htm

19. Akishita M, Kozaki K, Iijima K, Tanaka T, Shibasaki K, Ogawa S, et al. Chapter 1 Definition and diagnosis of sarcopenia. Geriatr Gerontol Int. 2018;18: 7–12. doi: 10.1111/ggi.13311 29745461

20. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48: 452–458. doi: 10.1038/bmt.2012.244 23208313

21. Heber D, Ingles S, Ashley JM, Maxwell MH, Lyons RF, Elashoff RM. Clinical detection of sarcopenic obesity by bioelectrical impedance analysis. Am J Clin Nutr. 1996;64: 472S–477S. doi: 10.1093/ajcn/64.3.472S 8780366

22. Prado CM, Wells JC, Smith SR, Stephan BC, Siervo M. Sarcopenic obesity: A critical appraisal of the current evidence. Clin Nutr. 2012;31: 583–601. doi: 10.1016/j.clnu.2012.06.010 22809635

23. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363: 157–163. 14726171

24. Czernichow S, Kengne AP, Stamatakis E, Hamer M, Batty GD. Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: evidence from an individual-participant meta-analysis of 82864 participants from nine cohort studies. Obes Rev. 2011;12: 680–687. doi: 10.1111/j.1467-789X.2011.00879.x 21521449

25. Nazare JA, Smith J, Borel AL, Aschner P, Barter P, Van Gaal L, et al. Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile(from the INSPIRE ME IAA study). Am J Cardiol. 2015;115: 307–315. doi: 10.1016/j.amjcard.2014.10.039 25499404

26. Miyawaki T, Abe M, Yahata K, Kajiyama N, Katsuma H, Saito N. Contribution of visceral fat accumulation to the risk factors for atherosclerosis in non-obese Japanese. Intern Med. 2004;43: 1138–1144. 15645647

27. Keele AM, Bray MJ, Emery PW, Duncan HD, Silk DB. Two phase randomized controlled clinical trial of postoperative oral dietary supplements in surgical patients. Gut. 1997;40: 393–399. doi: 10.1136/gut.40.3.393 9135531

28. Rana SK, Bray J, Menzies-Gow N, Jameson J, Payne James JJ, Frost P, et al. Short term benefits of post-operative oral dietary supplements in surgical patients. Clin Nutr. 1992;11: 337–344. 16840018

29. Smedley F, Bowling T, James M, Stokes E, Goodger C, O'Connor O, et al. Randomized clinical trial of the effects of preoperative and postoperative oral nutritional supplements on clinical course and cost care. Br J Surg. 2004;91: 983–990. 15286958

30. Imamura H, Nishikawa K, Kishi K, Matsuyama J, Akamaru Y, Kimura Y, et al. Effects of an oral elemental nutritional supplement on post-gastrectomy body weight loss in gastric cancer patients: A randomized controlled clinical trial. Ann Surg Oncol. 2016;23: 2928–2935. doi: 10.1245/s10434-016-5221-4 27084538

31. Mortensen K, Nilsson M, Slim K, Schäfer M, Mariette C, Braga M, et al. Consensus guidelines for enhanced recovery after gastrectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations. Br J Surg. 2014;101: 1209–1229. doi: 10.1002/bjs.9582 25047143

32. Kim JW, Kim WS, Cheong JH, Hyung WJ, Choi SH, Noh SH. Safety and efficacy of fast-track surgery in laparoscopic distal gastrectomy for gastric cancer: a randomized clinical trial. World J Surg. 2012;36: 2879–2887. doi: 10.1007/s00268-012-1741-7 22941233

33. Wray CJ, Mammen JM, Hasselgren PO. Catabolic response to stress and potential benefits of nutrition support. Nutrition. 2012;18: 971–977.

34. Wilmore DW. Postoperative protein sparing. World J Surg. 1999;23: 545–552. 10227922

35. Fiatarone MA, O'Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med. 1994;330: 1769–1775. 8190152

36. Cruz-Jentoft AJ, Landi F, Schneider SM, Zúñiga C, Arai H, Boirie Y, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43: 748–759. doi: 10.1093/ageing/afu115 25241753

37. Kim HK, Suzuki T, Saito K, Yoshida H, Kobayashi H, Kato H, et al. Effects of exercise and amino acid supplementation on body composition and physical function in community-dwelling elderly Japanese sarcopenic women: a randomized controlled trial. J Am Geriatr Soc. 2012;60: 16–23. doi: 10.1111/j.1532-5415.2011.03776.x 22142410


Článek vyšel v časopise

PLOS One


2019 Číslo 9
Nejčtenější tento týden
Nejčtenější v tomto čísle
Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Svět praktické medicíny 1/2024 (znalostní test z časopisu)
nový kurz

Koncepce osteologické péče pro gynekology a praktické lékaře
Autoři: MUDr. František Šenk

Sekvenční léčba schizofrenie
Autoři: MUDr. Jana Hořínková

Hypertenze a hypercholesterolémie – synergický efekt léčby
Autoři: prof. MUDr. Hana Rosolová, DrSc.

Význam metforminu pro „udržitelnou“ terapii diabetu
Autoři: prof. MUDr. Milan Kvapil, CSc., MBA

Všechny kurzy
Kurzy Podcasty Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

#ADS_BOTTOM_SCRIPTS#